Clinical features and outcome in a Danish cohort of juvenile dermatomyositis patients

被引:2
|
作者
Mathiesen, P. R. [1 ]
Zak, M. [2 ]
Herlin, T. [3 ]
Nielsen, S. M. [2 ]
机构
[1] Copenhagen Univ Hosp, Dept Paediat, Paediat Clin, DK-4300 Holbaek, Denmark
[2] Copenhagen Univ Hosp, Rigshosp, Paediat Rheumatol Unit, DK-4300 Holbaek, Denmark
[3] Aarhus Univ Hosp, Paediat Rheumatol Clin, Aarhus, Denmark
关键词
Juvenile dermatomyositis; outcome assessments; Myositis Damage Index; calcinosis; IDIOPATHIC INFLAMMATORY MYOPATHIES; NATIONAL-INSTITUTE; PROGNOSTIC-FACTORS; DISEASE; POLYMYOSITIS; ARTHRITIS; CHILDREN; DAMAGE; ONSET; MUSCULOSKELETAL;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To assess disease characteristics and outcome in Danish juvenile dermatomyositis (JDM) patients (1977-2007). Methods Medical record review of hospital records identified from the National Patient Register. Results Fifty-seven JDM patients were identified. Follow-up time was 7 years (range 0.06-30). Female:male ratio was 2.5:1. Mean age at disease onset was 7 years (SD +/- 3.7), range 1.5-16.0 years. Diagnostic delay was 0.7 years (SD +/- 1.6), range 0.04-9 years. Mean disease duration was 3.7 years (SD +/- 3.5), range 0.7-9 years. Thirty-nine patients (70%) were in full remission. Three patients (5%) were deceased. Disease/treatment-induced damage was present in 35 (61%) patients. Decreased pulmonary function occurred early in the disease course (median 10 months), osteoporosis and calcinosis occurred later (median 18 and 22 months). Four patients developed persistent damage within the first 6 months, four developed calcinosis within the first year. Shorter disease duration was associated with less damage (p=0.004). In a multivariate assessment analysis age > 10 years at disease onset was associated with more damage (p < 0.01), OR 10.96 (CI 1.6-73.6), and disease duration > 4 years was associated with calcinosis (p=0.01) OR 23.2 (CI 2.6-206.2). Conclusion We present a nationwide retrospective study of Danish JDM patients from 1977-2007. Although 70% were in remission, 61% of the patients had clinical signs of damage. Only a few patients developed damage within the first year of the disease. Longer disease duration and higher age at disease onset was correlated with more disease damage.
引用
收藏
页码:782 / 789
页数:8
相关论文
共 50 条
  • [31] Clinical characteristics of 88 patients with juvenile or adult dermatomyositis
    Constantin, T
    Ponyi, A
    Molnar, K
    Muller, J
    Szalai, Z
    Fekete, G
    Danko, K
    CLINICAL IMMUNOLOGY, 2005, 115 : S120 - S121
  • [32] CLINICAL AND LABORATORY ANALYSIS OF 10 PATIENTS WITH JUVENILE DERMATOMYOSITIS
    LAZAREVIC, MB
    PILIPOVIC, N
    VUKOTIC, D
    SKOSEY, JL
    ARTHRITIS AND RHEUMATISM, 1995, 38 (06): : R16 - R16
  • [33] Juvenile dermatomyositis: clinical and laboratory charateristics of 18 patients
    E Iglesias
    J Antón
    S Ricart
    J Ros
    V Torrente
    R Bou
    MA González
    A Vicente
    Pediatric Rheumatology, 9 (Suppl 1)
  • [34] Initial histological features in juvenile dermatomyositis may predict clinical progression
    Li, C
    Holton, JL
    Varsani, H
    Weaver, N
    Harding, B
    Woo, P
    Wedderburn, LR
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2005, 31 (02) : 230 - 230
  • [35] Predicting the Course of Juvenile Dermatomyositis Significance of Early Clinical and Laboratory Features
    Stringer, Elizabeth
    Singh-Grewal, Davinder
    Feldman, Brian M.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (11): : 3585 - 3592
  • [36] Clinical features of hemophagocytic syndrome in patients with dermatomyositis
    Yajima, Nobuyuki
    Wakabayashi, Kuninobu
    Odai, Tsuyoshi
    Isozaki, Takeo
    Matsunawa, Mizuho
    Miwa, Yusuke
    Negishi, Masao
    Ide, Hirotsugu
    Kasama, Tsuyoshi
    JOURNAL OF RHEUMATOLOGY, 2008, 35 (09) : 1838 - 1841
  • [37] CLINICAL AND SEROLOGIC FEATURES OF PATIENTS WITH POLYMYOSITIS OR DERMATOMYOSITIS
    HOLDEN, DJ
    BROWNELL, AKW
    FRITZLER, MJ
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1985, 132 (06) : 649 - 653
  • [38] Clinical Features and Cutaneous Manifestations of Juvenile and Adult Patients of Dermatomyositis Associated with Myositis-Specific Autoantibodies
    Okiyama, Naoko
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (08)
  • [39] Clinical outcomes in juvenile dermatomyositis
    Ramanan, AV
    Feldman, BM
    CURRENT OPINION IN RHEUMATOLOGY, 2002, 14 (06) : 658 - 662
  • [40] Clinical assessment in juvenile dermatomyositis
    Ravelli, Angelo
    Ruperto, Nicolino
    Trail, Lucia
    Felici, Enrico
    Sala, Elena
    Martini, Alberto
    AUTOIMMUNITY, 2006, 39 (03) : 197 - 203